Stock Quote

Confluent Announces Third Quarter 2021 Financial Results

  • Total revenue of $103 million, up 67% year over year
  • Confluent Cloud revenue of $27 million, up 245% year over year
  • Remaining performance obligations of $385 million, up 75% year over year
  • 664 customers with $100,000 or greater in ARR, up 48% year over year

Confluent, Inc. (NASDAQ: CFLT), the platform for data in motion, today announced financial results for its third quarter 2021, ended September 30, 2021.

“Harnessing the power of data in motion is a major factor in determining which organizations win in the modern era,” said Jay Kreps, co-founder and CEO, Confluent. “This imperative - combined with the massive cross-industry migration to the public cloud - has driven an acceleration to 245% year-over-year growth for Confluent Cloud as organizations look for a platform that connects and processes all of their data, everywhere it is.”

“We delivered our first quarter with more than one hundred million dollars in total revenue, a milestone for our business, and saw continued year-over-year growth acceleration in total revenue, Confluent Cloud revenue, and remaining performance obligations,” said Steffan Tomlinson, CFO, Confluent. “Our strong dollar-based net retention rate, which once again exceeded 130% in the third quarter, is a testament to the power of our data-in-motion platform and the strength of our go-to-market model.”

Third Quarter 2021 Financial Highlights

(In millions, except per share data and percentages)

 

Q3 2021

Q3 2020

Y/Y Change

Total Revenue

$102.6

$61.5

67%

Remaining Performance Obligations

$385.0

$220.2

75%

GAAP Operating Loss(1)

$(94.8)

$(140.0)

$45.2

Non-GAAP Operating Loss

$(42.6)

$(19.7)

$(22.9)

GAAP Net Loss Per Share(1)

$(0.37)

$(1.34)

$0.97

Non-GAAP Net Loss Per Share

$(0.17)

$(0.18)

$0.01

Net Cash Used in Operating Activities

$(18.0)

$(9.2)

$(8.8)

Free Cash Flow

$(20.6)

$(10.3)

$(10.3)

A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure is provided in the financial statement tables included in this press release. For a description of these non-GAAP financial measures, including the reasons management uses each measure, please see the section titled “Non-GAAP Financial Measures.”

(1) Includes the one-time impact of $111.9 million of stock-based compensation expense in connection with a tender offer and secondary sales of our common stock and convertible founder stock in Q3 2020.

Financial Outlook

For the fourth quarter and fiscal year 2021, Confluent expects:

 

Q4 2021 Outlook

Fiscal 2021 Outlook

Total Revenue

$108-$110 million

$376-$378 million

Non-GAAP Operating Loss

$(59)-$(57) million

$(170)-$(168) million

Non-GAAP Net Loss Per Share

$(0.23)-$(0.21)

$(0.92)-$(0.90)

A reconciliation of forward-looking non-GAAP operating loss and non-GAAP net loss per share to the most directly comparable GAAP measures is not available without unreasonable effort, as certain items cannot be reasonably predicted because of their high variability, complexity and low visibility. In particular, the measures and effects of our stock-based compensation expense specific to our equity compensation awards and employer payroll tax-related items on employee stock transactions are directly impacted by the timing of employee stock transactions and unpredictable fluctuations in our stock price, which we expect to have a significant impact on our future GAAP financial results.

Conference Call Information

Confluent will host a video webcast to discuss the company’s third quarter 2021 results as well as its financial outlook today at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. Open to the public, investors may access the webcast, earnings press release, supplemental financial information, and investor presentation on Confluent’s investor relations website at investors.confluent.io before the commencement of the webcast. A replay of the webcast will also be accessible from Confluent’s investor relations website a few hours after the conclusion of the live event.

IPO Lock-up Termination

As previously announced, beginning at the opening of trading on Monday, November 08, 2021, the lock-up agreements that Confluent’s directors, officers, and holders of substantially all of Confluent’s pre-IPO common stock and securities exercisable for or convertible into common stock, entered into with Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC, as representatives of the underwriters for Confluent’s recent initial public offering, will terminate.

Forward-Looking Statements

This press release and the earnings call referencing this press release contain forward-looking statements including, among other things, statements regarding our financial outlook; increased adoption of our platform; growth in total revenue, Confluent Cloud revenue, remaining performance obligations and dollar-based net retention rate; our ability and position to capitalize on the shift to cloud; and our market opportunity. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “seek,” “plan,” “project,” “target,” “looking ahead,” “look to,” “move into,” and similar expressions are intended to identify forward-looking statements. Forward-looking statements represent our current beliefs, estimates and assumptions only as of the date of this press release and information contained in this press release should not be relied upon as representing our estimates as of any subsequent date. These forward-looking statements are subject to risks, uncertainties, and assumptions. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Risks include, but are not limited to: (i) the impact of the ongoing COVID-19 pandemic on our business, as well as our customers, prospects, partners, and service providers, (ii) our ability to sustain and manage our rapid growth, (iii) our limited operating history, (iv) our ability to attract new customers and retain and sell additional features and services to our existing customers, (v) our ability to increase consumption of our offering, including by existing customers and through the acquisition of new customers, and successfully add new features and functionality to our offering, (vi) our ability to achieve or sustain profitability, (vii) the estimated addressable market opportunity for our offering, (viii) our ability to compete effectively in an increasingly competitive market, including achieving market acceptance over competitors and open source alternatives, (ix) our ability to attract and retain highly qualified personnel, (x) breaches in our security measures or unauthorized access to our platform, our data, or our customers’ or other users’ personal data, (xi) our reliance on third-party cloud-based infrastructure to host Confluent Cloud, and (xii) general market, political, economic, and business conditions. These risks are not exhaustive. Further information on these and other risks that could affect Confluent’s results is included in our filings with the Securities and Exchange Commission (“SEC”), including our Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, and our future reports that we may file from time to time with the SEC. Additional information will be made available in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 that will be filed with the SEC, which should be read in conjunction with this press release and the financial results included herein. Confluent assumes no obligation to, and does not currently intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Non-GAAP Financial Measures

This press release includes the following non-GAAP financial measures: non-GAAP operating loss, non-GAAP net loss per share and free cash flow. We use these non-GAAP financial measures and other key metrics internally to facilitate analysis of our financial and business trends and for internal planning and forecasting purposes. We believe these non-GAAP financial measures, when taken collectively, may be helpful to investors because they provide consistency and comparability with past financial performance by excluding certain items that may not be indicative of our business, results of operations, or outlook. However, non-GAAP financial measures have limitations as an analytical tool and are presented for supplemental informational purposes only. They should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. In particular, other companies, including companies in our industry, may report non-GAAP operating loss, non-GAAP net loss per share, free cash flow or similarly titled measures but calculate them differently, which reduces their usefulness as comparative measures. Further, free cash flow is not a substitute for cash used in operating activities. The utility of free cash flow is limited as such measure does not reflect our future contractual commitments and does not represent the total increase or decrease in our cash balance for any given period. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures, as presented below. We define non-GAAP operating loss and non-GAAP net loss per share as the respective GAAP balances, adjusted for, as applicable, stock-based compensation expense; employer taxes on employee stock transactions; common stock charitable donation expense; and income tax effects associated with these adjustments. We define free cash flow as net cash used in operating activities less capitalized internal-use software costs and capital expenditures. We believe that free cash flow is a useful indicator of liquidity that provides information to management and investors about the performance of core operations and future ability to generate cash that can be used for strategic opportunities or investing in our business.

Other Business Metrics

Remaining performance obligations (“RPO”) represent the amount of contracted future revenue that has not yet been recognized as of the end of each period, including both deferred revenue that has been invoiced and non-cancelable committed amounts that will be invoiced and recognized as revenue in future periods. RPO excludes pay-as-you-go arrangements. RPO may also fluctuate due to a number of factors, including the timing of renewals, average contract terms, seasonality, and dollar amount of customer contracts. RPO as a metric is not necessarily indicative of future revenue growth because it does not account for the timing of customers’ consumption or their consumption of more than their contracted capacity.

Customers with $100,000 or greater in annual recurring revenue (“ARR”) represent the number of customers that contributed $100,000 or more in ARR as of period end. ARR is the subscription revenue contractually expected to be received from customers over the following 12 months assuming no increases or reductions in subscriptions. ARR excludes services and pay-as-you-go arrangements. For purposes of determining our customer count, we treat all affiliated entities with the same parent organization as a single customer and include pay-as-you-go customers. Our customer count is subject to adjustments for acquisitions, consolidations, spin-offs, and other market activity.

Dollar-based net retention rate (“NRR”) as of a period end is calculated by starting with the ARR from the cohort of all customers as of 12 months prior to such period end (“Prior Period Value”). We calculate the ARR from these same customers as of the current period end (“Current Period Value”), which includes any growth in the value of subscriptions and is net of contraction or attrition over the prior 12 months. Services and pay-as-you-go arrangements are excluded from the calculation of ARR. We then divide the Current Period Value by the Prior Period Value to arrive at our dollar-based NRR. The dollar-based NRR includes the effect, on a dollar-weighted value basis, of our subscriptions that expand, renew, contract, or attrit, but excludes ARR from new customers in the current period. Our dollar-based NRR is subject to adjustments for acquisitions, consolidations, spin-offs, and other market activity.

About Confluent

Confluent is pioneering a fundamentally new category of data infrastructure focused on data in motion. Confluent’s cloud-native offering is the foundational platform for data in motion – designed to be the intelligent connective tissue enabling real-time data, from multiple sources, to constantly stream across the organization. With Confluent, organizations can meet the new business imperative of delivering rich, digital front-end customer experiences and transitioning to sophisticated, real-time, software-driven backend operations.

Confluent, Inc.

Condensed Consolidated Balance Sheets

(in thousands)

(unaudited)

 

September 30, 2021

 

December 31, 2020

ASSETS
Current assets:
Cash and cash equivalents

$

582,697

 

$

36,789

 

Marketable securities

 

448,245

 

 

251,756

 

Accounts receivable, net of allowance

 

116,006

 

 

105,971

 

Deferred contract acquisition costs

 

23,120

 

 

14,403

 

Prepaid expenses and other current assets

 

37,481

 

 

18,775

 

Total current assets

 

1,207,549

 

 

427,694

 

Property and equipment, net

 

11,892

 

 

6,718

 

Operating lease right-of-use assets

 

39,705

 

 

48,273

 

Deferred contract acquisition costs, non-current

 

43,748

 

 

33,196

 

Other assets, non-current

 

6,926

 

 

10,238

 

Total assets

$

1,309,820

 

$

526,119

 

LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable

$

3,327

 

$

1,646

 

Accrued expenses and other liabilities

 

66,721

 

 

33,711

 

Operating lease liabilities

 

9,819

 

 

10,492

 

Deferred revenue

 

179,696

 

 

142,901

 

Liability for early exercise of unvested stock options

 

13,238

 

 

5,049

 

Total current liabilities

 

272,801

 

 

193,799

 

Operating lease liabilities, non-current

 

33,720

 

 

40,440

 

Deferred revenue, non-current

 

22,398

 

 

16,292

 

Other liabilities, non-current

 

9,760

 

 

7,203

 

Total liabilities

 

338,679

 

 

257,734

 

Redeemable convertible preferred stock

 

-

 

 

574,634

 

Stockholders’ equity (deficit):
Preferred stock

 

-

 

 

-

 

Common stock

 

-

 

 

1

 

Convertible founder stock

 

-

 

 

-

 

Class A common stock

 

1

 

 

-

 

Class B common stock

 

2

 

 

-

 

Additional paid-in capital

 

1,605,341

 

 

99,575

 

Accumulated other comprehensive income

 

212

 

 

228

 

Accumulated deficit

 

(634,415

)

 

(406,053

)

Total stockholders’ equity (deficit)

 

971,141

 

 

(306,249

)

Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit)

$

1,309,820

 

$

526,119

 

Confluent, Inc.

Condensed Consolidated Statements of Operations

(in thousands, except share and per share data)

(unaudited)

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

2021

 

2020

 

2021

 

2020

Revenue:
Subscription

$

92,400

 

$

54,498

 

$

238,908

 

$

145,414

 

Services

 

10,170

 

 

6,999

 

 

29,028

 

 

20,839

 

Total revenue

 

102,570

 

 

61,497

 

 

267,936

 

 

166,253

 

Cost of revenue:
Subscription(1)(2)

 

25,489

 

 

12,373

 

 

61,538

 

 

35,121

 

Services(1)(2)

 

11,810

 

 

6,683

 

 

29,608

 

 

19,438

 

Total cost of revenue

 

37,299

 

 

19,056

 

 

91,146

 

 

54,559

 

Gross profit

 

65,271

 

 

42,441

 

 

176,790

 

 

111,694

 

Operating expenses:
Research and development(1)(2)

 

47,701

 

 

44,921

 

 

105,239

 

 

83,538

 

Sales and marketing(1)(2)

 

86,991

 

 

43,759

 

 

218,706

 

 

118,523

 

General and administrative(1)(2)

 

25,330

 

 

93,758

 

 

78,785

 

 

110,507

 

Total operating expenses

 

160,022

 

 

182,438

 

 

402,730

 

 

312,568

 

Operating loss

 

(94,751

)

 

(139,997

)

 

(225,940

)

 

(200,874

)

Interest income

 

299

 

 

1,259

 

 

1,831

 

 

3,005

 

Other expense, net

 

(530

)

 

(153

)

 

(1,509

)

 

(671

)

Loss before income taxes

 

(94,982

)

 

(138,891

)

 

(225,618

)

 

(198,540

)

Provision for (benefit from) income taxes

 

684

 

 

(750

)

 

2,744

 

 

(468

)

Net loss

$

(95,666

)

$

(138,141

)

$

(228,362

)

$

(198,072

)

Net loss per share attributable to common stockholders, basic and diluted

$

(0.37

)

$

(1.34

)

$

(1.40

)

$

(1.91

)

Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted

 

259,152,303

 

 

102,852,461

 

 

162,728,527

 

 

103,856,815

 

(1) Includes stock-based compensation expense as follows:

Three Months Ended September 30,

 

Nine Months Ended September 30,

2021

 

2020

 

2021

 

2020

Cost of revenue - subscription

$

3,945

 

$

883

 

$

7,092

 

$

1,869

Cost of revenue - services

 

1,790

 

 

671

 

 

3,389

 

 

1,333

Research and development

 

16,310

 

 

26,522

 

 

28,753

 

 

30,818

Sales and marketing

 

18,516

 

 

6,379

 

 

34,647

 

 

11,487

General and administrative

 

9,122

 

 

85,619

 

 

23,671

 

 

88,090

Total stock-based compensation expense

$

49,683

 

$

120,074

$

97,552

 

$

133,597

*

   
* In connection with a tender offer and secondary sales of our common stock and convertible founder stock, stock-based compensation for the three and nine months ended September 30, 2020 included $111.9 million of expense related to the amount paid in excess of the estimated fair value of common stock as of the date of the transactions.
(2) Includes employer taxes on employee stock transactions as follows:

Three Months Ended September 30,

 

Nine Months Ended September 30,

2021

 

2020

 

2021

 

2020

Cost of revenue - subscription

$

117

 

$

8

 

$

155

 

$

9

Cost of revenue - services

 

49

 

 

16

 

 

337

 

 

16

Research and development

 

601

 

 

45

 

 

999

 

 

54

Sales and marketing

 

1,236

 

 

35

 

 

1,949

 

 

57

General and administrative

 

436

 

 

92

 

 

697

 

 

141

Total employer taxes on employee stock transactions

$

2,439

 

$

196

 

$

4,137

 

$

277

Confluent, Inc.

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2021

 

 

 

2020

 

 

 

2021

 

 

 

2020

 

CASH FLOWS FROM OPERATING ACTIVITIES
Net loss

$

(95,666

)

$

(138,141

)

$

(228,362

)

$

(198,072

)

Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization

 

897

 

 

488

 

 

2,440

 

 

1,187

 

Net amortization of premiums or discounts on marketable securities

 

536

 

 

436

 

 

1,500

 

 

778

 

Amortization of deferred contract acquisition costs

 

6,739

 

 

4,125

 

 

18,322

 

 

10,253

 

Non-cash operating lease costs

 

2,962

 

 

2,943

 

 

8,566

 

 

9,045

 

Common stock charitable donation expense

 

-

 

 

-

 

 

13,290

 

 

-

 

Stock-based compensation, net of amounts capitalized

 

49,683

 

 

120,074

 

 

97,552

 

 

133,597

 

Deferred income taxes

 

(1

)

 

(906

)

 

1,729

 

 

(1,038

)

Other

 

1,023

 

 

110

 

 

1,671

 

 

379

 

Changes in operating assets and liabilities:
Accounts receivable

 

979

 

 

1,738

 

 

(10,874

)

 

(23,599

)

Deferred contract acquisition costs

 

(11,244

)

 

(9,548

)

 

(37,592

)

 

(23,475

)

Prepaid expenses and other assets

 

(2,616

)

 

(3,829

)

 

(17,339

)

 

(3,977

)

Accounts payable

 

1,366

 

 

1,530

 

 

1,737

 

 

(105

)

Accrued expenses and other liabilities

 

18,597

 

 

5,915

 

 

31,490

 

 

8,199

 

Operating lease liabilities

 

(2,834

)

 

(2,726

)

 

(8,216

)

 

(8,493

)

Deferred revenue

 

11,550

 

 

8,616

 

 

42,902

 

 

33,659

 

Net cash used in operating activities

 

(18,029

)

 

(9,175

)

 

(81,184

)

 

(61,662

)

CASH FLOWS FROM INVESTING ACTIVITIES
Capitalization of internal-use software costs

 

(2,052

)

 

(870

)

 

(3,863

)

 

(2,967

)

Purchases of marketable securities

 

(322,941

)

 

(52,730

)

 

(378,912

)

 

(283,420

)

Sales of marketable securities

 

-

 

 

-

 

 

-

 

 

4,988

 

Maturities of marketable securities

 

57,693

 

 

70,226

 

 

180,667

 

 

106,986

 

Purchases of property and equipment

 

(563

)

 

(209

)

 

(2,236

)

 

(693

)

Other

 

3

 

 

-

 

 

12

 

 

-

 

Net cash (used in) provided by investing activities

 

(267,860

)

 

16,417

 

 

(204,332

)

 

(175,106

)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from initial public offering, net of underwriting discounts and commissions

 

-

 

 

-

 

 

786,600

 

 

-

 

Proceeds from issuance of common stock upon exercise of vested options

 

10,421

 

 

4,413

 

 

29,126

 

 

7,000

 

Proceeds from issuance of common stock upon early exercise of unvested options, net of repurchases

 

24

 

 

2,493

 

 

18,567

 

 

3,331

 

Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs

 

-

 

 

10,000

 

 

-

 

 

259,865

 

Payments of deferred offering costs

 

(2,205

)

 

-

 

 

(3,125

)

 

-

 

Net cash provided by financing activities

 

8,240

 

 

16,906

 

 

831,168

 

 

270,196

 

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

 

(1

)

 

51

 

 

(11

)

 

18

 

Net (decrease) increase in cash, cash equivalents, and restricted cash

 

(277,650

)

 

24,199

 

 

545,641

 

 

33,446

 

Cash, cash equivalents, and restricted cash at beginning of period

 

861,097

 

 

29,218

 

 

37,806

 

 

19,971

 

Cash, cash equivalents, and restricted cash at end of period

$

583,447

 

$

53,417

 

$

583,447

 

$

53,417

 

Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown above:
Cash and cash equivalents

$

582,697

 

$

52,400

 

$

582,697

 

$

52,400

 

Restricted cash included in other assets, non-current

 

750

 

 

1,017

 

 

750

 

 

1,017

 

Total cash, cash equivalents, and restricted cash

$

583,447

 

$

53,417

 

$

583,447

 

$

53,417

 

Confluent, Inc.

Reconciliation of GAAP Measures to Non-GAAP Measures

(in thousands, except percentages, share and per share data)

(unaudited)

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2021

 

 

 

2020

 

 

 

2021

 

 

 

2020

 

Reconciliation of GAAP total gross profit to non-GAAP total gross profit:
Total gross profit on a GAAP basis

$

65,271

 

$

42,441

 

$

176,790

 

$

111,694

 

Total gross margin on a GAAP basis

 

63.6

%

 

69.0

%

 

66.0

%

 

67.2

%

Add: Stock-based compensation expense(1)

 

5,735

 

 

1,554

 

 

10,481

 

 

3,202

 

Add: Employer taxes on employee stock transactions

 

166

 

 

24

 

 

492

 

 

25

 

Non-GAAP total gross profit

$

71,172

 

$

44,019

 

$

187,763

 

$

114,921

 

Non-GAAP total gross margin

 

69.4

%

 

71.6

%

 

70.1

%

 

69.1

%

 
Reconciliation of GAAP operating expenses to non-GAAP operating expenses:
Research and development operating expense on a GAAP basis

$

47,701

 

$

44,921

 

$

105,239

 

$

83,538

 

Less: Stock-based compensation expense(1)

 

16,310

 

 

26,522

 

 

28,753

 

 

30,818

 

Less: Employer taxes on employee stock transactions

 

601

 

 

45

 

 

999

 

 

54

 

Non-GAAP research and development operating expense

$

30,790

 

$

18,354

 

$

75,487

 

$

52,666

 

Non-GAAP research and development operating expense as a percentage of total revenue

 

30.0

%

 

29.8

%

 

28.2

%

 

31.7

%

 
Sales and marketing operating expense on a GAAP basis

$

86,991

 

$

43,759

 

$

218,706

 

$

118,523

 

Less: Stock-based compensation expense(1)

 

18,516

 

 

6,379

 

 

34,647

 

 

11,487

 

Less: Employer taxes on employee stock transactions

 

1,236

 

 

35

 

 

1,949

 

 

57

 

Non-GAAP sales and marketing operating expense

$

67,239

 

$

37,345

 

$

182,110

 

$

106,979

 

Non-GAAP sales and marketing operating expense as a percentage of total revenue

 

65.6

%

 

60.7

%

 

68.0

%

 

64.3

%

 
General and administrative operating expense on a GAAP basis

$

25,330

 

$

93,758

 

$

78,785

 

$

110,507

 

Less: Stock-based compensation expense(1)

 

9,122

 

 

85,619

 

 

23,671

 

 

88,090

 

Less: Employer taxes on employee stock transactions

 

436

 

 

92

 

 

697

 

 

141

 

Less: Common stock charitable donation expense

 

-

 

 

-

 

 

13,290

 

 

-

 

Non-GAAP general and administrative operating expense

$

15,772

 

$

8,047

 

$

41,127

 

$

22,276

 

Non-GAAP general and administrative operating expense as a percentage of total revenue

 

15.4

%

 

13.1

%

 

15.3

%

 

13.4

%

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2021

 

 

 

2020

 

 

 

2021

 

 

 

2020

 

Reconciliation of GAAP operating loss to non-GAAP operating loss:
Operating loss on a GAAP basis

$

(94,751

)

$

(139,997

)

$

(225,940

)

$

(200,874

)

Add: Stock-based compensation expense(1)

 

49,683

 

 

120,074

 

 

97,552

 

 

133,597

 

Add: Employer taxes on employee stock transactions

 

2,439

 

 

196

 

 

4,137

 

 

277

 

Add: Common stock charitable donation expense

 

-

 

 

-

 

 

13,290

 

 

-

 

Non-GAAP operating loss

$

(42,629

)

$

(19,727

)

$

(110,961

)

$

(67,000

)

Non-GAAP operating margin

 

(41.6

%)

 

(32.1

%)

 

(41.4

%)

 

(40.3

%)

 
Reconciliation of GAAP net loss to non-GAAP net loss:
Net loss on a GAAP basis

$

(95,666

)

$

(138,141

)

$

(228,362

)

$

(198,072

)

Add: Stock-based compensation expense(1)

 

49,683

 

 

120,074

 

 

97,552

 

 

133,597

 

Add: Employer taxes on employee stock transactions

 

2,439

 

 

196

 

 

4,137

 

 

277

 

Add: Common stock charitable donation expense

 

-

 

 

-

 

 

13,290

 

 

-

 

Add: Income tax effects and adjustments

 

(20

)

 

(987

)

 

1,025

 

 

(1,414

)

Non-GAAP net loss

$

(43,564

)

$

(18,858

)

$

(112,358

)

$

(65,612

)

Non-GAAP net loss per share attributable to common stockholders, basic and diluted

$

(0.17

)

$

(0.18

)

$

(0.69

)

$

(0.63

)

Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted

 

259,152,303

 

 

102,852,461

 

 

162,728,527

 

 

103,856,815

 

(1) In connection with a tender offer and secondary sales of our common stock and convertible founder stock, stock-based compensation for the three and nine months ended September 30, 2020 included $0.6 million, $23.9 million, $3.5 million, and $83.9 million of expense within cost of revenue, research and development expense, sales and marketing expense, and general and administrative expense, respectively, for an aggregate of $111.9 million of expense related to the amount paid in excess of the estimated fair value of common stock as of the date of the transactions.

The following table presents a reconciliation of free cash flow to net cash used in operating activities, the most directly comparable GAAP measure, for each of the periods indicated (unaudited, in thousands):

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2021

 

 

 

2020

 

 

 

2021

 

 

 

2020

 

Net cash used in operating activities

$

(18,029

)

$

(9,175

)

$

(81,184

)

$

(61,662

)

Capitalized internal-use software costs

 

(2,052

)

 

(870

)

 

(3,863

)

 

(2,967

)

Capital expenditures

 

(563

)

 

(209

)

 

(2,236

)

 

(693

)

Free cash flow

$

(20,644

)

$

(10,254

)

$

(87,283

)

$

(65,322

)

Free cash flow margin

 

(20.1

%)

 

(16.7

%)

 

(32.6

%)

 

(39.3

%)

Net cash provided by (used in) investing activities

$

(267,860

)

$

16,417

 

$

(204,332

)

$

(175,106

)

Net cash provided by financing activities

$

8,240

 

$

16,906

 

$

831,168

 

$

270,196

 

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.